Application of targeted imaging combined with fine needle aspiration in diagnosis of lymph node metastases for precise treatment plan in differentiated thyroid cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028095

Enrollment

Unknown

Registered

2019-12-11

Start date

2019-12-11

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Gold Standard:Pathology

Index test:Fine-needle&#32

aspiration-Tg,&#32

99mTcO4-&#32

&&#32

99mTc-3PRGD2&#32

imaging

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. DTC patients aged 18-70 years with a clear clinical diagnosis; 2. Clinical data can be obtained for a complete evaluation of the efficacy; 3. Patients with a complete plan of clinical treatment can follow up the patient's progression-free survival (PFS); 4. Volunteer and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe liver and kidney damage 2. Pathology or long-term follow-up results may not be available; 3. Unable to obtain relevant control image data and clinical data; 4. Combined with other malignant tumors; 5. Beyond the age range or severely difficult to cooperate; 6. Failure to follow up on PFS; 7. Withdrawal of informed consent; 8. Missed follow-up; 9. Violates the research plan.

Design outcomes

Primary

Measure	Time frame
99mTc-3PRGD2 imaging;FNA-Tg;Thyroid scan;	—

Countries

China

Contacts

Public ContactRui Gao

The First Affiliated Hospital, Medical School of Xi'an Jiaotong University

Jacky_mg@163.com+86 13772488039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026